Immunotherapy and patients treated for cancer with microsatellite instability.
We present a comprehensive overview of MSI phenotype, its biological landscape and current diagnostic methods. Then we focus on MSI as a predictive biomarker of response to immune checkpoint inhibition in the context of colorectal cancer and non-colorectal tumors.
PMID: 27979364 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Colle R, Cohen R, Cochereau D, Duval A, Lascols O, Lopez-Trabada D, Afchain P, Trouilloud I, Parc Y, Lefevre JH, Fléjou JF, Svrcek M, André T Tags: Bull Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Endometrial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Gastroschisis Repair | Genetics | HNPCC | Immunotherapy | Lynch Syndrome